Consider this scenario (this is purely speculation and my opinion only):
The early results from the European Phase III show dramatic response. The published news leads to a world-wide clamour for the treatment to be fast-tracked so it is available to sufferers as soon as possible.
Clearly there are hoops that all treatments must jump through, but the FDA recognises that some treatments need to be brought to market much faster than the normal processes allow and has specific provision for such a treatment:
http://www.fda.gov/forconsumers/byaudience/forpatientadvocates/speedingaccesstoimportantnewtherapies/ucm128291.htm
Early safety data already reported (see Primas announcement to the ASX 1/2/2011) would facillitate such a decision I would have thought.
Any guesses on a SP in this (hypothetical) scenario??
My guess is that the current SP in retrospect will make a bargain look like a ripoff!
- Forums
- ASX - By Stock
- IMM
- sellers
sellers, page-43
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMM (ASX) to my watchlist
(20min delay)
|
|||||
Last
35.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $515.6M |
Open | High | Low | Value | Volume |
35.0¢ | 36.0¢ | 34.5¢ | $670.1K | 1.893M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 44785 | 35.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
35.5¢ | 22453 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 44785 | 0.350 |
4 | 38370 | 0.345 |
4 | 50195 | 0.340 |
2 | 38254 | 0.335 |
2 | 80000 | 0.330 |
Price($) | Vol. | No. |
---|---|---|
0.355 | 2653 | 1 |
0.360 | 139050 | 5 |
0.365 | 107554 | 5 |
0.370 | 140060 | 4 |
0.375 | 127910 | 5 |
Last trade - 16.10pm 19/08/2024 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |